Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/28521
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17744/20032 (89%)
Visitors : 7238582      Online Users : 326
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item:

    Title: Behavior-selective Apoptotic Capacity of 4-(3,4,5-Trimethoxyphenoxy) Benzoic Acid and its Methyl Derivatives on Two Breast Cancer Cell Lines
    Authors: Lee, Kuan-Han
    Ho, Wen-Yueh
    Wu, Shu-Jing
    Cheng, Tsung-Lin
    Huang, Po-Jui
    Wang, Clay C. C.
    Hung, Jui-Hsiang
    Contributors: 藥學系
    Keywords: MCF-7
    colony formation
    breast cancer
    Date: 2014-04
    Issue Date: 2015-05-06 21:19:16 (UTC+8)
    Publisher: Int Inst Anticancer Research
    Abstract: Breast cancer is one of the most common tumors in females. The therapeutic resistance of breast cancer has motivated the development of new agents for prevention and treatment. For the present study, several compounds were designed and analyzed for their antitumor activity in many cancer cell lines. 4-(3,4,5-Trimethoxyphenoxy) benzoic acid (compound 1) and its derivatives were selected for studying the anti-proliferative and cytotoxic effects on five human cancer cell lines. Results indicated that compounds 1 and 2 significantly suppressed the cell viability of MCF-7 and MDA-MB-468 cancer cells. However, compounds 1 and 2 had only minor effects on HepG2, Huh-7, and Hela cells. Moreover, compounds I and 2 exhibited a novel anti-tumor activity through the induction of cell-cycle arrest at G(2)/M and apoptosis in MCF-7 and MDA-MB-486 breast cancer cells. Both compounds reduced colony-forming ability in MCF-7 cells. Flow cytometric analysis indicated that caspase-3 activity was increased in response to treatment with compounds 1 and 2. Taken together, these findings suggest that the novel compounds 1 and 2 are potential anticancer agents with clinical promise for breast cancer therapy.
    Relation: Anticancer Research, v.34 n.4, pp.1801-1809
    Appears in Collections:[Dept. of Biotechnology (including master's program)] Periodical Articles
    [Dept. of Health and Nutrition (including master's program)] Periodical Articles
    [Dept. of Cosmetic Science and institute of cosmetic science] Periodical Articles
    [Dept. of Pharmacy] Periodical Articles

    Files in This Item:

    There are no files associated with this item.

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback